phar 751 dietary effects on metabolism sarah brown, pharm.d. pharmacy practice resident asante...
TRANSCRIPT
PHAR 751 Dietary Effects on Metabolism
Sarah Brown, Pharm.D.Pharmacy Practice Resident
Asante Health [email protected]
Metabolism: P-gp review
• Substrate + Inhibitor =
• Substrate + Inducer =
CYP Metabolism
• Cytochrome P450 – Gene superfamily: families subfamilies enzyme– Oxidative metabolism – Phase I– Location
• Liver• Small intestine
– Most abundant P450 is CYP3A4– Induction =– Inhibition =
Metabolism: CYP review
• Substrate + Inhibitor =
• Substrate + Inducer =
Metabolism & Diet
• Food– Macronutrients
• Protein• CHO• Fats
– Micronutrients• Vitamins• Minerals• Indoles
• Drink– Grapefruit juice– Orange juice– Seville orange juice– Alcohol
Diet can alter enzyme activity influence the intensity & duration of action
Macronutrients: Protein Intake
• 20% of diet
• Malnutrition contributes to variability in drug metabolism
• CYP-mediated– In rats: CYP3A activity ↓ from 18% to 1% w/
↓protein intake– CYP1A2 ↓ w/ 0.5% protein diet– CYP1A1: no change
Protein intake & theophylline metabolism
• CYP-mediated
• ↓ in Cl of 30% when reduce protein intake from 20% to 10%
• ↓ t½ from 8-9 h to 6 h by increasing protein from 10% to 40%.
• TPN patients lower plasma Cl
Another route of metabolism: FMO1
• Flavin-containing monooxygenase (FMO) 1 protein
• Oxidative metabolism
• Non-inducible
• Influenced by dietary intake
Micronutrient: Indole effect on metabolism
• Indole-3-carbinol (I3C) – Naturally-occurring
chemical found in cruciferous vegetables
– Induces CYP1A1– Inhibits FMO1– Also marketed as
dietary supplement
Katchamart, et al. Concurrent flavin-containing monooxygenase down-regulation and cytochrome p-450 induction by dietary indoles in rat: implications for drug-drug interaction. Drug Metabolism and Disposition 2000; 28 (8): 930 – 936.
Influence of dietary I3C on FMO1 protein levels
Katchamart, et al. Concurrent flavin-containing monooxygenase down-regulation and cytochrome p-450 induction by dietary indoles in rat: implications for drug-drug interaction. Drug Metabolism and Disposition 2000; 28 (8): 930 – 936.
FMO (-) and CYP (+)
Katchamart, et al. Concurrent flavin-containing monooxygenase down-regulation and cytochrome p-450 induction by dietary indoles in rat: implications for drug-drug interaction. Drug Metabolism and Disposition 2000; 28 (8): 930 – 936.
Micronutrient: Indole effect on metabolism of tamoxifen
Katchamart, et al. Concurrent flavin-containing monooxygenase down-regulation and cytochrome p-450 induction by dietary indoles in rat: implications for drug-drug interaction. Drug Metabolism and Disposition 2000; 28 (8): 930 – 936.
Why do we care?
• Clinical relevance– Drug-drug or drug-food interactions– Potential for altered toxicity of drugs that are
substrates for FMO and CYP – Potential altered efficacy (i.e. tamoxifen)– I3C & DIM dietary supplements
Alcohol & Tobacco effects on metabolism
• 80 – 95% alcoholics smoke (25 – 30% non-alcoholics smoke)– 70% are heavy smokers
• Those who drink & smoke more cigarettes/day
• Correlation between alcohol intake & tobacco use
• Association w/ environmental and genetic factors?
Schoedel KA, Tyndale RF. Induction of nicotine-metabolizing CYP2B1 by ethanol and ethanol-metabolizing CYP2E1 by nicotine: summary and implications. Biochimica et Biophysica Acta 1619 (2003) 283– 290.
Alcohol & Nicotine: types of tolerance
• Tolerance
• Cross tolerance
• Functional cross-tolerance
• Metabolic cross-tolerance
Schoedel KA, Tyndale RF. Induction of nicotine-metabolizing CYP2B1 by ethanol and ethanol-metabolizing CYP2E1 by nicotine: summary and implications. Biochimica et Biophysica Acta 1619 (2003) 283– 290.
Alcohol & Nicotine metabolism
• Alcohol– Primarily by ADH– 20% by CYP2E1 (up to 60% at high BAC)
• Nicotine– Metabolized by CYP2A6 (and CYP2B6 in
humans; CYP2B1 in rats ) cotinine (inactive)
Schoedel KA, Tyndale RF. Induction of nicotine-metabolizing CYP2B1 by ethanol and ethanol-metabolizing CYP2E1 by nicotine: summary and implications. Biochimica et Biophysica Acta 1619 (2003) 283– 290.
CYP2E1
• CYP2E1– Also metabolizes APAP, isoniazid, tamoxifen,
halothane– Inducible by both EtOH & nicotine– Potential for altering efficacy of clinically used
substrates
Schoedel KA, Tyndale RF. Induction of nicotine-metabolizing CYP2B1 by ethanol and ethanol-metabolizing CYP2E1 by nicotine: summary and implications. Biochimica et Biophysica Acta 1619 (2003) 283– 290.
Alcohol + Nicotine + CYP2E1 = ?
• ↑ expression of CYP2E1 (induced by nicotine and EtOH) ↑ metabolism of EtOH = metabolic cross-
tolerance
more EtOH required for same effect = tolerance
Schoedel KA, Tyndale RF. Induction of nicotine-metabolizing CYP2B1 by ethanol and ethanol-metabolizing CYP2E1 by nicotine: summary and implications. Biochimica et Biophysica Acta 1619 (2003) 283– 290.
Study in rats
• Up-regulation of brain CYP2B1 & CYP2E1 by EtOH
Nicotine metabolized by CYP2B1 = metabolic cross tolerance
Schoedel KA, Tyndale RF. Induction of nicotine-metabolizing CYP2B1 by ethanol and ethanol-metabolizing CYP2E1 by nicotine: summary and implications. Biochimica et Biophysica Acta 1619 (2003) 283– 290.
Metabolism & Diet
√ Food – protein
√ Drink – alcohol
next: citrus juices
Flavonoids
• Naturally occurring in citrus fruits
• Known for antioxidant activity
• Flavonoids– Flavone
• Flavanone• Flavonol
• Potential for drug-interactions
PK Study: Felodipine & Grapefruit juice
• Substrate: felodipine
• Enzyme inhibitor: grapefruit juice– Inhibits CYP3A4 & CYP1A2
• What happens to felodipine concentrations?
Lown et al. Grapefruit Juice Increases Felodipine Oral Availability in Humans by Decreasing Intestinal CYP3A Protein Expression. J Clin Invest. 1997; 99(19): 2545-2553.
Naringin
• A flavonoid• Metabolized to the
flavonone, naringenin• “bitter” component of
grapefruit juice• 800 mg/L• ~100 g flesh = 200 mL
regular strength juice• Inhibits CYP3A4 &
CYP1A2
Quercetin
• A Flavonol• Average daily intake 16 – 25
mg/day• Adjunct to cisplatin,
cyclophosphamide, and adriamycin tx
• Chelates metal ions; acts as free radical scavenger
• ↓ CAD mortality; ↓ stroke incidence
• Dietary supplementation: 1 – 1.5 g/day
• Known to inhibit oxidation of nifedipine and felodipine
Felodipine
• A dihydropyridine calcium channel blocker
• Reversibly competes w/ other CCBs for dhp-binding sites– Blocks voltage-
dependent Ca2+ currents in vascular smooth muscle
Felodipine + Grapefruit juice
• Study: Recurrent administration of grapefruit juice & felodipine kinetics
• Hypothesis: continuous administration of grapefruit juice increased intestinal CYP3A4 diminishing effect on felodipine kinetics
Lown et al. Grapefruit Juice Increases Felodipine Oral Availability in Humans by Decreasing Intestinal CYP3A Protein Expression. J Clin Invest. 1997; 99(19): 2545-2553.
CYP3A4 concentration in study participants
• Drop in the CYP3A4 enterocyte concentration in all subjects
Lown et al. Grapefruit Juice Increases Felodipine Oral Availability in Humans by Decreasing Intestinal CYP3A Protein Expression. J Clin Invest. 1997; 99(19): 2545-2553.
↓ CYP3A4 following GFJ administration
Lown et al. Grapefruit Juice Increases Felodipine Oral Availability in Humans by Decreasing Intestinal CYP3A Protein Expression. J Clin Invest. 1997; 99(19): 2545-2553.
All CYPs? Or just 3A4?
“…no consistent change in the level of enterocyte CYP2D6 or CYP1A1 protein with recurrent grapefruit juice ingestion.”
Lown et al. Grapefruit Juice Increases Felodipine Oral Availability in Humans by Decreasing Intestinal CYP3A Protein Expression. J Clin Invest. 1997; 99(19): 2545-2553.
Clinical interactions: felodipine & GFJ
∆ = after 5 days GFJ tid
○ = after first glass GFJ
● = Water
Lown et al. Grapefruit Juice Increases Felodipine Oral Availability in Humans by Decreasing Intestinal CYP3A Protein Expression. J Clin Invest. 1997; 99(19): 2545-2553.
Conclusion: Felodipine + Grapefruit juice
• Study: Recurrent administration of grapefruit juice & felodipine kinetics
• Hypothesis: continuous administration of grapefruit juice increased intestinal CYP3A4 diminishing effect on felodipine kinetics– Result: decrease in intestinal CYP3A4 in all
subjects
Lown et al. Grapefruit Juice Increases Felodipine Oral Availability in Humans by Decreasing Intestinal CYP3A Protein Expression. J Clin Invest. 1997; 99(19): 2545-2553.
Thursday’s lecture 3/1/07
Terfenadine
• Second-generation H1-receptor antagonist
• Rapidly and almost completely metabolized by CYP3A4
• Active metabolite
• Cardiotoxic drug-drug interactions w/ erythromycin and ketoconazole
Benton, et al. Grapefruit juice alters terfenadine pharmacokinets, resulting in prolonged repolarization on the electrocardiogram. Clin Pharmacol Ther. 1996; 59: 383-8.
PK study: Terfenadine & Grapefruit juice
• Study: Is bioavailability of terfenadine enhanced by GFJ? – Does timing of terfenadine dose and
administration of GFJ matter?
Benton, et al. Grapefruit juice alters terfenadine pharmacokinets, resulting in prolonged repolarization on the electrocardiogram. Clin Pharmacol Ther. 1996; 59: 383-8.
PK study: Terfenadine & Grapefruit juice
• Primary endpoints: QT prolongation, AUC, Cmax, Tmax
• 60 mg terfenadine bid x 7d– + 240 mL GFJ w/ terfenadine x 7d– OR + 240 mL GFJ 2 h after terfenadine dose
x 7 d– EKG and plasma level on day 7 and day 14
PK study: Terfenadine & Grapefruit juice
A: Simultaneous GFJ administration B: GFJ 2 hours after terfenadine
Benton, et al. Grapefruit juice alters terfenadine pharmacokinetics, resulting in prolonged repolarization on the electrocardiogram. Clin Pharmacol Ther. 1996; 59: 383-8.
PD: Terfenadine & Grapefruit juice
A: Simultaneous GFJ administration B: GFJ 2 hours after terfenadine
Benton, et al. Grapefruit juice alters terfenadine pharmacokinetics, resulting in prolonged repolarization on the electrocardiogram. Clin Pharmacol Ther. 1996; 59: 383-8.
Benton, et al. Grapefruit juice alters terfenadine pharmacokinetics, resulting in prolonged repolarization on the electrocardiogram. Clin Pharmacol Ther. 1996; 59: 383-8.
PK study: Terfenadine & GFJ conclusions
• PK interaction: Increases terfenadine concentration in some subjects
• Effect more pronounced when administered together– Delayed effect likely d/t rapid absorption of
terfenadine
• Interaction occurs in gut wall CYP3A enzymes• ↑ concentration increase in QTc interval on
EKG
Benton, et al. Grapefruit juice alters terfenadine pharmacokinetics, resulting in prolonged repolarization on the electrocardiogram. Clin Pharmacol Ther. 1996; 59: 383-8.
Another study: Felodipine, water, grapefruit juice
• PK of IV and PO felodipine
• Grapefruit juice or water 15 min prior to dose of felodipine
• 10 mg ER tablet or 1.5 mg IV over 60 min
• Measured SBP, DBP, and HR
Lundahl J, Regardh CG, Edgar B, Johnsson G. Effects of grapefruit juice ingestion ± pharmacokinetics and haemodynamics of intravenously and orally administered felodipine in healthy men. Eur J Clin Pharmacol. 1997;52:139-145.
PK: Felodipine
PO felodipine w/ water
IV felodipine w/ GFJ
IV felodipine w/ water
PO felodipine w/ GFJ
Lundahl J, Regardh CG, Edgar B, Johnsson G. Effects of grapefruit juice ingestion ± pharmacokinetics and haemodynamics of intravenously and orally administered felodipine in healthy men. Eur J Clin Pharmacol. 1997;52:139-145.
PK data
Lundahl J, Regardh CG, Edgar B, Johnsson G. Effects of grapefruit juice ingestion ± pharmacokinetics and haemodynamics of intravenously and orally administered felodipine in healthy men. Eur J Clin Pharmacol. 1997;52:139-145.
Hemodynamic effects in relation to PK
• Oral felodipine + GFJ ↓ DBP (12 – 19 mmHg); ↓ HR
• Effects were similar for IV felodipine w/ water & GFJ
Lundahl J, Regardh CG, Edgar B, Johnsson G. Effects of grapefruit juice ingestion ± pharmacokinetics and haemodynamics of intravenously and orally administered felodipine in healthy men. Eur J Clin Pharmacol. 1997;52:139-145.
Hemodynamic data
Study: Felodipine & GFJ conclusions
• Metabolism of felodipine occurred in gut wall
• Increased plasma concentrations w/ oral felodipine & GFJ increase hemodynamic effects
Clinical Application
• GFJ: ↑ oral availability of commonly used medications
• Is the interaction significant?
Grapefruit juice & Seville Orange juice
• Furocoumarins– Bergamottin (16 μM GFJ; 5 μM SOJ)– 6’,7’-dihyroxybergamottin (10-60 (23) μM
GFJ; 36 μM SOJ)– Bergapten (31 μM SOJ only)
Study: Seville Orange juice, GFJ, & felodipine
• Juice equimolar concentration
• Single dose felodipine– Seville orange juice– Dilute GFJ– Common orange juice (-) control
• Hypothesis: furocoumarins are involved in the “grapefruit juice interaction”
Malhotra et al. Seville orange juice-felodipine interaction: Comparison with dilute grapefruit juice and involvement of furocoumarins. 2001; 69(1):14-23.
Conc vs. time - felodipine
Malhotra et al. Seville orange juice-felodipine interaction: Comparison with dilute grapefruit juice and involvement of furocoumarins. 2001; 69(1):14-23.
PK data: felodipine
PK data following a single dose of felodipine taken with 8 ounces SOJ, GFJ, or OJ
Malhotra et al. Seville orange juice-felodipine interaction: Comparison with dilute grapefruit juice and involvement of furocoumarins. 2001; 69(1):14-23.
Study conclusions
• Sufficient bergamottin and 6’,7’-dihydroxybergamottin concentrations
drug-interaction
• More furocoumarins? drug-interactions
Just in case…• Cyclosporine: Edwards et al. 6’,7’-dihydroxybergamottin in grapefruit
juice and Seville orange juice: Effects on cyclosporine disposition, enterocyte CYP3A4, and P-glycoprotein. Clin Pharmacol Ther 1999;65(3): 237-44.
• Pranidipine: Hashimoto et al. Interaction of citrus juices with pranidipine, a new 1,4-dihydropyridine calcium antagonist, in healthy subjects. Eur J Clin Pharmacol 1998;54:753-60.
• Celiprolol: Lilja JJ, Juntti-Patinen L, Neuvonen PJ. Orange juice substantially reduces the bioavailability of the β-adrenergic-blocking agent celiprolol. Clin Pharmacol Ther 2004;75(3):184-90.
• Fexofenadine: Dresser et al. Fruit juices inhibit organic anion transporting polypeptide-mediated drug uptake to decrease the oral availability of fexofenadine. Clin Pharmacol Ther 2002;71(1):11-20.
http://www.theage.com.au/ffximage/2007/02/04/svWAVE_wideweb__470x371,0.jpg
St John’s Wort
St John’s Wort
• Known CYP3A4 induction
• Reports of interactions with:– Theophylline (CYP1A2)– Amitriptyline ((CYP2D6, CYP1A2)– Warfarin (CYP2C9)– Digoxin (p-gp substrate)
Wang et al. The effects of St John’s wort (Hypericum perforatum) on human cytochrome P450 activity. Clin Pharmacol Ther 2001;70(4):317-26.
PK study: St John’s wort & CYP
• Interaction at the level of CYP?
• Which CYPs are involved?
• Induction? Inhibition?
• Three part study (control, short-term dosing, long-term dosing)
Wang et al. The effects of St John’s wort (Hypericum perforatum) on human cytochrome P450 activity. Clin Pharmacol Ther 2001;70(4):317-26.
Study drugs
• Tolbutamide (CYP2C9)
• Caffeine (CYP2A1)
• Dextromethorphan (CYP2D6)
• Oral midazolam (intestinal wall and hepatic CYP3A)
• IV midazolam (hepatic CYP3A)
Wang et al. The effects of St John’s wort (Hypericum perforatum) on human cytochrome P450 activity. Clin Pharmacol Ther 2001;70(4):317-26.
PK study: St John’s wort & CYP
• Control: tolbutamide, caffeine, DM po, and versed IV, then oral versed 24 h later
• Short-term: 900mg St John’s wort then same as above, + 2nd dose of 900mg then St John’s wort x 14-15 additional days
• Long-term: 900mg St John’s wort then same as above, + 2nd dose of 900mg
PK study: St John’s wort & CYP
IV oral
□ before St John’s wort
○ after St John’s wort (short-term phase)
♦ after St John’s wort (long-term phase)
Short-term: no change
Long-term: 50% reduction in oral AUC and Cmax
PK data
Short-term: no change
Long-term: 50% reduction in oral AUC and Cmax
Study drugs
• Tolbutamide (CYP2C9)
• Caffeine (CYP2A1)
• Dextromethorphan (CYP2D6)
• Oral midazolam (intestinal wall and hepatic CYP3A)
• IV midazolam (hepatic CYP3A)
Wang et al. The effects of St John’s wort (Hypericum perforatum) on human cytochrome P450 activity. Clin Pharmacol Ther 2001;70(4):317-26.
Other outcomes
• Oral caffeine – CYP1A2 NS
• Oral tolbutamide – CYP2C9 NS
• Oral DM – CYP2D6 NS
• Interaction = CYP3A4
Study conclusions
• Induction of CYP3A by St John’s wort
• Long-term use ↓ efficacy of drugs metabolized by CYP3A
Lycopene
Lycopene
• ~80% of dietary lycopene from tomatoes and tomato products
• Most abundant carotenoid in human plasma
• Evidence for beneficial effects preventing prostate cancer
• Availability from tomatoes is improved with processing (puree > raw)
Cohn et al. Comparative multiple dose plasma kinetics of lycopene administered in tomato juice, tomato soup or lycopene tablets. Eur J Nutr 2004;43:304-12.
Lycopene study
• Lycopene depletion phase
• Each group ~20mg lycopene daily x 8d
• Three tx groups– Juice– Soup– Tablet
Cohn et al. Comparative multiple dose plasma kinetics of lycopene administered in tomato juice, tomato soup or lycopene tablets. Eur J Nutr 2004;43:304-12.
Lycopene study
Cohn et al. Comparative multiple dose plasma kinetics of lycopene administered in tomato juice, tomato soup or lycopene tablets. Eur J Nutr 2004;43:304-12.
Lycopene concentration: juice vs. soup vs. tablet
Cohn et al. Comparative multiple dose plasma kinetics of lycopene administered in tomato juice, tomato soup or lycopene tablets. Eur J Nutr 2004;43:304-12.
Conclusions
• Processing releases lycopene for absorption– Also causes conversion to all-E-lycopene, the
most stable configuration
• 8 days of tomato product double the average concentration from baseline